ELIZABETH A PFEIFFER
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Child & Adolescent Psychiatry FORT WAYNE, IN NPI 1124252879
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Child & Adolescent Psychiatry IN Otsuka America Pharmaceutical, Inc. All categories
General Payments — all program years on this page
$1,127.47
- Category: General Payments
- Program years: PY2018–2024
- Record count: 67
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $154.47 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $154.47 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $46.16 | 2 |
| Alkermes, Inc. | $38.33 | 2 |
| Janssen Pharmaceuticals, Inc | $18.29 | 1 |
| Teva Pharmaceuticals USA, Inc. | $18.17 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.05 | 1 |
| ITI, Inc. | $16.47 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078016854 | Janssen Pharmaceuticals, Inc | $18.29 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118906741 | Otsuka America Pharmaceutical, Inc. | $24.73 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118906743 | Otsuka America Pharmaceutical, Inc. | $21.43 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120573017 | Alkermes, Inc. | $21.31 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120573019 | Alkermes, Inc. | $17.02 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137573217 | Takeda Pharmaceuticals U.S.A., Inc. | $17.05 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143241208 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16.47 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151582907 | Teva Pharmaceuticals USA, Inc. | $18.17 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.